Compare BioNano Genomics Inc (BNGO) vs Paycom Software Inc (PAYC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNano Genomics Inc vs Paycom Software Inc — how do they compare? BioNano Genomics Inc trades at $1.18 (market cap $13.66M), while Paycom Software Inc trades at $211 (market cap $9.57B). The key difference: Paycom Software Inc is far larger — about 700.6× BioNano Genomics Inc's market cap, and Paycom Software Inc pays a 0.71% dividend while BioNano Genomics Inc pays none. Which is the better fit depends on your goals.
| BNGO | PAYC | |
|---|---|---|
Market Cap | $13.66M | $9.57B |
Sector | Health | Technology |
52-Week High | $4.92 | $233.89 |
52-Week Low | $1.06 | $113.59 |
Enterprise Value | $16.26M | $10.35B |
Dividend Yield | — | 0.71% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BNGO trades at $1.195, up 3.02% today, with a bullish technical signal from moving averages but a neutral oscillator stance. The company shows improving financial trends, with net losses narrowing to -$26.40M in 2025 from -$232M in 2023, and recent earnings beats. Revenue stabilized around $29M, while cash flow trends indicate reduced operational cash burn. Analyst sentiment is positive, with 57% buy ratings.
The outlook for BNGO hinges on sustaining revenue growth and achieving profitability, supported by strategic hires and debt retirement. Key risks include persistent negative margins and high cash burn. With a low P/S of 0.31, the stock offers value if execution improves, but investors face volatility from operational challenges and competitive pressures.
Paycom Software (PAYC) trades at $206.16, down 3.42% today but maintains strong fundamentals with consistent earnings beats and robust profitability. The stock shows bullish technical momentum with recent Q2 2026 results exceeding expectations, driven by 10% revenue growth and margin expansion. AI-driven demand and automation savings support management's raised 2026 outlook.
Outlook remains positive with analyst consensus target of $219.22 offering 6% upside. Key risks include valuation multiples above sector averages and competitive pressures. The company's strong cash flow generation and dividend payments provide shareholder value support amid market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →About Paycom Software Inc
Paycom is a fast-growing provider of payroll and human capital management, or HCM, software primarily targeting clients with 50-10,000 employees in the United States. Paycom was established in 1998 and services about 18,000 clients as of 2021, based on parent company grouping. Alongside its core payroll software, Paycom offers various HCM add-on modules, including time and attendance, talent management, and benefits administration.
Read more on PAYC →
